1. Home
  2. WS vs HRMY Comparison

WS vs HRMY Comparison

Compare WS & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Steel Inc.

WS

Worthington Steel Inc.

HOLD

Current Price

$38.20

Market Cap

1.8B

Sector

N/A

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$32.44

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WS
HRMY
Founded
1955
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
WS
HRMY
Price
$38.20
$32.44
Analyst Decision
Buy
Buy
Analyst Count
2
9
Target Price
$42.50
$44.11
AVG Volume (30 Days)
198.0K
799.5K
Earning Date
03-25-2026
05-07-2026
Dividend Yield
1.76%
N/A
EPS Growth
N/A
7.97
EPS
1.30
2.71
Revenue
$3,093,300,000.00
$868,453,000.00
Revenue This Year
$16.77
$19.75
Revenue Next Year
$2.69
$12.88
P/E Ratio
$29.95
$11.72
Revenue Growth
N/A
21.51
52 Week Low
$24.36
$25.52
52 Week High
$49.17
$40.87

Technical Indicators

Market Signals
Indicator
WS
HRMY
Relative Strength Index (RSI) 60.43 66.25
Support Level $38.01 $32.13
Resistance Level $39.29 $33.21
Average True Range (ATR) 1.51 1.32
MACD 0.49 0.19
Stochastic Oscillator 76.47 58.88

Price Performance

Historical Comparison
WS
HRMY

About WS Worthington Steel Inc.

Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: